KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 161 filers reported holding KARUNA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $507 | -56.6% | 2,339 | -63.7% | 0.01% | -58.3% |
| Q1 2023 | $1,169 | +1.4% | 6,436 | +9.6% | 0.01% | 0.0% |
| Q4 2022 | $1,153 | -100.0% | 5,870 | -75.5% | 0.01% | -81.0% |
| Q3 2022 | $5,390,000 | +5.3% | 23,963 | -40.7% | 0.06% | +26.0% |
| Q1 2022 | $5,121,000 | -20.0% | 40,393 | -17.3% | 0.05% | -12.3% |
| Q4 2021 | $6,400,000 | +0.8% | 48,851 | -5.8% | 0.06% | -3.4% |
| Q3 2021 | $6,347,000 | +7.3% | 51,886 | 0.0% | 0.06% | +9.3% |
| Q2 2021 | $5,914,000 | -0.9% | 51,886 | +4.5% | 0.05% | -8.5% |
| Q1 2021 | $5,968,000 | +70.3% | 49,639 | +43.9% | 0.06% | +68.6% |
| Q4 2020 | $3,505,000 | +31.4% | 34,500 | 0.0% | 0.04% | +16.7% |
| Q3 2020 | $2,668,000 | -34.4% | 34,500 | -5.5% | 0.03% | -37.5% |
| Q2 2020 | $4,068,000 | +54.8% | 36,500 | 0.0% | 0.05% | +29.7% |
| Q1 2020 | $2,628,000 | – | 36,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 1,952,441 | $150,963,000 | 11.19% |
| Eventide Asset Management | 901,077 | $69,671,000 | 1.36% |
| First Light Asset Management, LLC | 128,200 | $9,912,000 | 1.02% |
| Prosight Management, LP | 15,826 | $1,224,000 | 0.58% |
| MOODY ALDRICH PARTNERS LLC | 30,970 | $2,395,000 | 0.50% |
| PFM Health Sciences, LP | 137,960 | $10,667,000 | 0.49% |
| Rock Springs Capital Management LP | 244,106 | $18,874,000 | 0.48% |
| Atika Capital Management LLC | 73,500 | $5,683,000 | 0.46% |
| Hood River Capital Management LLC | 132,400 | $10,237,000 | 0.44% |
| CATALYST PRIVATE WEALTH, LLC | 5,006 | $387,000 | 0.38% |